Inovio Pharma (INO) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.09 -2.68%
EPS Growth %: +60.7%
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
DIT, AMC, DPZ, More
EPS Growth %: +60.7%
Financial Fact:
Grant and miscellaneous revenue: 9.41M
Today's EPS Names:
DIT, AMC, DPZ, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.09), $0.04 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $5.52 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA expects Apple to top analyst expectations on July 30
- RBC Capital on Honeywell Aerospace Inc (HONA): 'Execution the key to addressing Bull/Bear debate'
- DA Davidson Reiterates Buy Rating on Tractor Supply Company (TSCO) Amid Soft Q2 Expectations
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
